Up-regulation of two actin-associated proteins prompts pulmonary artery smooth muscle cell migration under hypoxia

American Journal of Respiratory Cell and Molecular Biology

Volumn 41, Issue 4, 2009, Pages 467-475

  Zhang, Ruifeng ^a   Zhou, Lin ^b   Li, Qingyun ^a   Liu, Jialin ^a   Yao, Weiyan ^b   Wan, Huanying ^a  

^a SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

CapG; Hypoxia migration; Hypoxia inducible factor 1 ; Transgelin

Indexed keywords

ACTIN; BINDING PROTEIN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; PROTEIN CAPG; TRANSGELIN; UNCLASSIFIED DRUG;

ARTERY MUSCLE; ARTICLE; CELL MIGRATION; CELL MOTILITY; CONTROLLED STUDY; HUMAN; HUMAN CELL; HYPOXIA; HYPOXIC PULMONARY HYPERTENSION; IN VITRO STUDY; MUSCLE CELL; PATHOGENESIS; PROTEIN EXPRESSION; PROTEOMICS; PULMONARY ARTERY; PULMONARY HYPERTENSION;

CELL HYPOXIA; CELL MOVEMENT; CELLS, CULTURED; HUMANS; HYPERTENSION, PULMONARY; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MICROFILAMENT PROTEINS; MUSCLE PROTEINS; MYOCYTES, SMOOTH MUSCLE; NUCLEAR PROTEINS; PULMONARY ARTERY; RNA INTERFERENCE; RNA, MESSENGER; RNA, SMALL INTERFERING; TRANSCRIPTION, GENETIC; UP-REGULATION;

EID: 68549090907     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.2008-0333OC     Document Type: Article

References (49)

1. Meyrick B, Reid L. The effect of chronic hypoxia on pulmonary arteries in young rats. Exp Lung Res 1981;2:257-271. (Pubitemid 12253148)
2. Hopkins N, McLoughlin P. The structural basis of pulmonary hypertension in chronic lung disease: remodelling, rarefaction or angiogenesis? J Anat 2002;201:335-348.
3. Nagaoka T, Fagan KA, Gebb SA, Morris KG, Suzuki T, Shimokawa H, McMurtry IF, Oka M. Inhaled rho kinase inhibitors are potent and selective vasodilators in rat pulmonary hypertension. Am J Respir Crit Care Med 2005;171:494-499. (Pubitemid 40444250)
4. Bloch KD, Ichinose F, Roberts JD Jr, Zapol WM. Inhaled NO as a therapeutic agent. Cardiovasc Res 2007;75:339-348.
5. Bixby CE, Ibe BO, Abdallah MF, Zhou W, Hislop AA, Longo LD, Raj JU. Role of platelet-activating factor in pulmonary vascular remodeling associated with chronic high altitude hypoxia in ovine fetal lambs. Am J Physiol 2007;293:L1475-L1482. (Pubitemid 350255031)
6. Yu AY, Shimoda LA, Iyer NV, Huso DL, Sun X, McWilliams R, Beaty T, Sham JS, Wiener CM, Sylvester JT, et al. Impaired physiological responses to chronic hypoxia in mice partially deficient for hypoxia-inducible factor 1alpha. J Clin Invest 1999;103:691-696. (Pubitemid 29122422)
7. Yu L, Quinn DA, Garg HG, Hales CA. Cyclin-dependent kinase inhibitor p27kip1, but not p21waf1/cip1, is required for inhibition of hypoxia-induced pulmonary hypertension and remodeling by heparin in mice. Circ Res 2005;97:937-945. (Pubitemid 41552680)
8. Qi JG, Ding YG, Tang CS, Du JB. Chronic administration of adrenomedullin attenuates hypoxic pulmonary vascular structural remodeling and inhibits proadrenomedullin n-terminal 20-peptide production in rats. Peptides 2007;28:910-919.
9. Raiesdana A, Loscalzo J. Pulmonary arterial hypertension. Ann Med 2006;38:95-110.
10. Silacci P, Mazzolai L, Gauci C, Stergiopulos N, Yin HL, Hayoz D. Gelsolin superfamily proteins: key regulators of cellular functions. Cell Mol Life Sci 2004;61:2614-2623. (Pubitemid 39586521)
11. Yu FX, Johnston PA, Sudhof TC, Yin HL. Gcap39, a calcium ion- and polyphosphoinositide-regulated actin capping protein. Science 1990;250:1413-1415.
12. Thompson CC, Ashcroft FJ, Patel S, Saraga G, Vimalachandran D, Prime W, Campbell F, Dodson A, Jenkins RE, Lemoine NR, et al. Pancreatic cancer cells overexpress gelsolin family-capping proteins, which contribute to their cell motility. Gut 2007;56:95-106. (Pubitemid 46044895)
13. Pellieux C, Desgeorges A, Pigeon CH, Chambaz C, Yin H, Hayoz D, Silacci P. Cap G, a gelsolin family protein modulating protective effects of unidirectional shear stress. J Biol Chem 2003;278:29136-29144. (Pubitemid 36935829)
14. Witke W, Li W, Kwiatkowski DJ, Southwick FS. Comparisons of capg and gelsolin-null macrophages: demonstration of a unique role for capg in receptor-mediated ruffling, phagocytosis, and vesicle rocketing. J Cell Biol 2001;154:775-784. (Pubitemid 34292959)
15. Sun HQ, Kwiatkowska K, Wooten DC, Yin HL. Effects of capg overexpression on agonist-induced motility and second messenger generation. J Cell Biol 1995;129:147-156.
16. Assinder SJ, Stanton JA, Prasad PD. Transgelin: an actin-binding protein and tumour suppressor. International J Biochem Cell Biol 2009;41:482-486.
17. Lees-Miller JP, Heeley DH, Smillie LB. An abundant and novel protein of 22 kda (sm22) is widely distributed in smooth muscles: purification from bovine aorta. Biochem J 1987;244:705-709.
18. Gimona M, Kaverina I, Resch GP, Vignal E, Burgstaller G. Calponin repeats regulate actin filament stability and formation of podosomes in smooth muscle cells. Mol Biol Cell 2003;14:2482-2491. (Pubitemid 36724336)
19. Wang GL, Jiang BH, Rue EA, Semenza GL. Hypoxia-inducible factor 1 is a basic-helix-loop-helix-pas heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci USA 1995;92:5510-5514.
20. Huang LE, Gu J, Schau M, Bunn HF. Regulation of hypoxia-inducible factor 1alpha is mediated by an o2-dependent degradation domain via the ubiquitin-proteasome pathway. Proc Natl Acad Sci USA 1998;95:7987-7992. (Pubitemid 28326053)
21. Semenza GL. Expression of hypoxia-inducible factor 1: mechanisms and consequences. Biochem Pharmacol 2000;59:47-53.
22. Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001;29:e45.
23. Ema M, Taya S, Yokotani N, Sogawa K, Matsuda Y, Fujii-Kuriyama Y. A novel bhlh-pas factor with close sequence similarity to hypoxia-inducible factor 1alpha regulates the VEGF expression and is potentially involved in lung and vascular development. Proc Natl Acad Sci USA 1997;94:4273-4278. (Pubitemid 27194231)
24. Yu AY, Frid MG, Shimoda LA, Wiener CM, Stenmark K, Semenza GL. Temporal, spatial, and oxygen-regulated expression of hypoxia-inducible factor-1 in the lung. Am J Physiol 1998;275:L818-L826.
25. Eul B, Rose F, Krick S, Savai R, Goyal P, Klepetko W, Grimminger F, Weissmann N, Seeger W, Hanze J. Impact of HIF-1alpha and HIF- 2alpha on proliferation and migration of human pulmonary artery fibroblasts in hypoxia. FASEB J 2006;20:163-165. (Pubitemid 43100501)
26. Frid MG, Aldashev AA, Dempsey EC, Stenmark KR. Smooth muscle cells isolated from discrete compartments of the mature vascular media exhibit unique phenotypes and distinct growth capabilities. Circ Res 1997;81:940-952.
27. Schultz K, Fanburg BL, Beasley D. Hypoxia and hypoxia-inducible factor-1alpha promote growth factor-induced proliferation of human vascular smooth muscle cells. Am J Physiol 2006;290:H2528-H2534.
28. Eddahibi S, Humbert M, Fadel E, Raffestin B, Darmon M, Capron F, Simonneau G, Dartevelle P, Hamon M, Adnot S. Serotonin transporter overexpression is responsible for pulmonary artery smooth muscle hyperplasia in primary pulmonary hypertension. J Clin Invest 2001;108:1141-1150. (Pubitemid 32995372)
29. Eddahibi S, Adnot S. Anorexigen-induced pulmonary hypertension and the serotonin (5-HT) hypothesis: lessons for the future in pathogenesis. Respir Res 2002;3:9. (Pubitemid 41358126)
30. Pietra GG, Capron F, Stewart S, Leone O, Humbert M, Robbins IM, Reid LM, Tuder RM. Pathologic assessment of vasculopathies in pulmonary hypertension. J Am Coll Cardiol 2004;43:25S-32S. (Pubitemid 38759714)
31. Day RM, Agyeman AS, Segel MJ, Chevere RD, Angelosanto JM, Suzuki YJ, Fanburg BL. Serotonin induces pulmonary artery smooth muscle cell migration. Biochem Pharmacol 2006;71:386-397. (Pubitemid 41817297)
32. Li M, Liu Y, Dutt P, Fanburg BL, Toksoz D. Inhibition of serotonin-induced mitogenesis, migration, and ERK MAPK nuclear translocation in vascular smooth muscle cells by atorvastatin. Am J Physiol Lung Cell Mol Physiol 2007;293:L463-L471. (Pubitemid 47205027)
33. Liu Y, Li M, Warburton RR, Hill NS, Fanburg BL. The 5-HT transporter transactivates the PDGFbeta receptor in pulmonary artery smooth muscle cells. FASEB J 2007;21:2725-2734. (Pubitemid 47372740)
34. Wu D, Doods H, Stassen JM. Inhibition of human pulmonary artery smooth muscle cell proliferation and migration by sabiporide, a new specific nhe-1 inhibitor. J Cardiovasc Pharmacol 2006;48:34-40. (Pubitemid 44358892)
35. Young CL, Southwick FS, Weber A. Kinetics of the interaction of a 41- kilodalton macrophage capping protein with actin: promotion of nucleation during prolongation of the lag period. Biochemistry 1990;29:2232-2240. (Pubitemid 20095465)
36. Van Impe K, De Corte V, Eichinger L, Bruyneel E, Mareel M, Vandekerckhove J, Gettemans J. The nucleo-cytoplasmic actin-binding protein capg lacks a nuclear export sequence present in structurally related proteins. J Biol Chem 2003;278:17945-17952. (Pubitemid 36799401)
37. Condeelis J, Singer RH, Segall JE. The great escape: when cancer cells hijack the genes for chemotaxis and motility. Annu Rev Cell Dev Biol 2005;21:695-718. (Pubitemid 41740651)
38. Iacobuzio-Donahue CA, Maitra A, Olsen M, Lowe AW, van Heek NT, Rosty C, Walter K, Sato N, Parker A, Ashfaq R, et al. Exploration of global gene expression patterns in pancreatic adenocarcinoma using cDNA microarrays. Am J Pathol 2003;162:1151-1162. (Pubitemid 36350660)
39. Sotiropoulos A, Gineitis D, Copeland J, Treisman R. Signal-regulated activation of serum response factor is mediated by changes in actin dynamics. Cell 1999;98:159-169. (Pubitemid 29344904)
40. Tapon N, Hall A. Rho, rac and CDC42 gtpases regulate the organization of the actin cytoskeleton. Curr Opin Cell Biol 1997;9:86-92. (Pubitemid 27065113)
41. Degryse B, Resnati M, Rabbani SA, Villa A, Fazioli F, Blasi F. Src-dependence and pertussis-toxin sensitivity of urokinase receptor-dependent chemotaxis and cytoskeleton reorganization in rat smooth muscle cells. Blood 1999;94:649-662. (Pubitemid 29323879)
42. Chen BH, Tzen JT, Bresnick AR, Chen HC. Roles of rho-associated kinase and myosin light chain kinase in morphological and migratory defects of focal adhesion kinase-null cells. J Biol Chem 2002;277:33857-33863.
43. Van den Abbeele A, De Corte V, Van Impe K, Bruyneel E, Boucherie C, Bracke M, Vandekerckhove J, Gettemans J. Downregulation of gelsolin family proteins counteracts cancer cell invasion in vitro. Cancer Lett 2007;255:57-70. (Pubitemid 47212607)
44. Lawson D, Harrison M, Shapland C. Fibroblast transgelin and smooth muscle sm22alpha are the same protein, the expression of which is down-regulated in many cell lines. Cell Motil Cytoskeleton 1997;38:250-257. (Pubitemid 27484089)
45. Yu H, Konigshoff M, Jayachandran A, Handley D, Seeger W, Kaminski N, Eickelberg O. Transgelin is a direct target of TGF-beta/Smad3- dependent epithelial cell migration in lung fibrosis. FASEB J 2008;22:1778-1789. (Pubitemid 351811455)
46. Lavie L. Obstructive sleep apnoea syndrome: an oxidative stress disorder. Sleep Med Rev 2003;7:35-51. (Pubitemid 36188305)
47. Yamashita T, Ohneda K, Nagano M, Miyoshi C, Kaneko N, Miwa Y, Yamamoto M, Ohneda O, Fujii-Kuriyama Y. Hypoxia-inducible transcription factor-2alpha in endothelial cells regulates tumor neovascularization through activation of ephrin a1. J Biol Chem 2008;283:18926-18936.
48. Yang Z, Chang YJ, Miyamoto H, Ni J, Niu Y, Chen Z, Chen YL, Yao JL, di Sant'Agnese PA, Chang C. Transgelin functions as a suppressor via inhibition of ara54-enhanced androgen receptor transactivation and prostate cancer cell growth. Mol Endocrinol (Baltimore) 2007;21:343-358. (Pubitemid 46184889)
49. Nair RR, Solway J, Boyd DD. Expression cloning identifies transgelin (sm22) as a novel repressor of 92-kDa type IV collagenase (MMP-9) expression. J Biol Chem 2006;281:26424-26436. (Pubitemid 44401851)